Ostalo

Clinical Significance of Autoantibodies Induced by Infliximab Treatment: Two-Year Follow-up after Infliximab Discontinuation

Srđan Novak ; Department of Rheumatology and Clinical Immunology, University Department of Medicine, Rijeka University Hospital Center, Rijeka, Croatia
Branimir Anić ; Department of Rheumatology and Clinical Immunology, University Department of Medicine, University Hospital Center Zagreb, Zagreb, Croatia
Felina Anić ; Department of Rheumatology and Clinical Immunology, University Department of Medicine, Rijeka University Hospital Center, Rijeka, Croatia
Mislav Cerovac ; Department of Rheumatology and Clinical Immunology, University Department of Medicine, University Hospital Center Zagreb, Zagreb, Croatia
Nada Čikeš ; Department of Rheumatology and Clinical Immunology, University Department of Medicine, University Hospital Center Zagreb, Zagreb, Croatia

Sažetak

Ključne riječi

anti-TNFa drugs; autoantibodies; drug induced lupus; infliximab

Hrčak ID:

89038

URI

https://hrcak.srce.hr/89038

Datum izdavanja:

1.3.2011.

Posjeta: 958 *